Antiandrogens fail to block androstenedione‐mediated mutated androgen receptor transactivation in human prostate cancer cells

This publication has 11 references indexed in Scilit:

• Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
  Proceedings of the National Academy of Sciences, 1998
• Hydroxyflutamide may not always be a pure antiandrogen
  The Lancet, 1997
• Hormonal therapy in the management of prostate cancer: From Huggins to the present
  Urology, 1997
• Codon 877 Mutation in the Androgen Receptor Gene in Advanced Prostate Cancer: Relation to Antiandrogen Withdrawal Syndrome
  The Prostate, 1996
• Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: implications for the actions of androgens and antiandrogens.
  Endocrinology, 1996
• Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
  New England Journal of Medicine, 1995
• Androgen receptor alterations in prostatic carcinoma
  The Prostate, 1994
• Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors
  The Journal of Steroid Biochemistry and Molecular Biology, 1993
• Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation
  Biochemistry, 1992
• Benefits of Combination Therapy with Flutamide in Patients Relapsing after Castration
  British Journal of Urology, 1988